Adc Therapeutics SA

NYSE:ADCT   10:02:38 AM EDT
21.10
-0.13 (-0.61%)
Earnings Announcements

ADC Therapeutics Reports Fourth Quarter And Year-End 2020 Results

Published: 03/18/2021 11:23 GMT
Adc Therapeutics SA (ADCT) - Q4 Diluted Loss per Share 0.73 USD Versus 0.69 USD Loss Year Ago.
Qtrly Net Loss per Share, Basic and Diluted $0.73.
Qtrly Adjusted Net Loss per Share, Basic and Diluted $0.82.
Revenue is expected to be $2.37 Million
Adjusted EPS is expected to be -$0.83

Next Quarter Revenue Guidance is expected to be $6.58 Million
Next Quarter EPS Guidance is expected to be -$0.79

More details on our Analysts Page.